RecruitingNCT06291311

Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants

Treatment of Infections of the Cervix Uteri With High- and Low-risk Variants of the Human Papillomavirus Using Non-invasive Physical Plasma

Sponsor

University Hospital Tuebingen

Enrollment

50 participants

Start Date

Dec 27, 2023

Study Type

OBSERVATIONAL

Conditions

Cervical Cancer HPV Infection

Summary

This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a non-invasive plasma treatment (NIPP) — a device that uses ionized gas — to treat HPV (human papillomavirus) infections of the cervix, including both high-risk and low-risk strains. HPV can cause cervical cell changes that may lead to cancer. **You may be eligible if...** - You are 18 or older - You have tested positive for HPV by a swab test - The affected area of your cervix (transformation zone) and lesion borders are clearly visible and classified as T1 or T2 - You are willing to provide written consent **You may NOT be eligible if...** - The affected area of your cervix cannot be fully seen - There is evidence of invasive (spreading) disease - You have a serious heart or lung condition - You are pregnant - You have a pacemaker or metal implants Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCold physical Plasma

The treatment is administered by either the supervising specialists or assistant doctors at the University Women's Hospital, under their supervision and authorization. It's important to note that the NIPP treatment is designed to be relatively brief, with a duration not exceeding 10-20 minutes.

OTHERControl group

A potential natural healing of the HPV infection will be anticipated